CD8A and neoplasm: LRIG1, expressed on CD8+ T cells, interact with VISTA in cis or trans to suppresses anti-tumor immunity by inducing quiescence in CD8+ T cells and limiting the development of effector T cells from progenitor and memory-like cells (40).